Glynamic-Mv 3/0.3 mg Tablet

Composition of Glynamic-Mv 3/0.3 mg Tablet

Glynamic-Mv 3/0.3 mg Tablet contains Glimepiride 3 mg + Voglibose 0.3 mg tablet. It belongs to the Sulfonylurea + Alpha-glucosidase inhibitor class of medicines.

Uses of Glynamic-Mv 3/0.3 mg Tablet

Type 2 diabetes mellitus to improve blood glucose control when diet and exercise alone are not adequate; may be used when dual therapy is required for post‑meal and fasting glucose control.

Key benefits

• Lowers fasting blood sugar
• Reduces post-meal glucose spikes
• Improves overall glycaemic control
• Helps reduce HbA1c when used with diet and exercise

How Glynamic-Mv 3/0.3 mg Tablet works

Glimepiride (a sulfonylurea) increases insulin release from the pancreas and improves insulin sensitivity. Voglibose (an alpha‑glucosidase inhibitor) delays intestinal carbohydrate digestion and absorption, reducing post‑meal blood sugar spikes.

How to take Glynamic-Mv 3/0.3 mg Tablet

Take orally as prescribed by the doctor, usually once daily with the first main meal (or just before meals as advised). Swallow whole with water; do not skip meals after taking it. Monitor blood glucose regularly.

Take it exactly as your doctor prescribed. Do not change the dose or stop early on your own.

Missed dose and overdose

If you miss a dose

Take it as soon as you remember. If your next dose is almost due, skip the one you missed — never take two doses together to catch up.

If you take too much

An overdose of this medicine can cause severe and prolonged low blood sugar, which may lead to fits or unconsciousness. It may cause low blood sugar and marked stomach upset. Do not wait for symptoms to appear — go to the nearest emergency department and take the pack or strip with you.

Side effects of Glynamic-Mv 3/0.3 mg Tablet

Most side effects of Glynamic-Mv 3/0.3 mg are mild and settle as the body adjusts. Reported side effects include:

• Hypoglycaemia
• dizziness
• headache
• nausea
• abdominal pain
• flatulence
• diarrhoea
• bloating
• increased liver enzymes

Stop the medicine and seek help immediately for a rash, swelling of the face or lips, wheezing or difficulty breathing. Tell your doctor about any side effect that persists or worries you.

Safety advice for Glynamic-Mv 3/0.3 mg Tablet

Warnings and precautions

Risk of low blood sugar—more likely with missed meals, alcohol, strenuous exercise, or with other antidiabetics; carry glucose. Use with caution in kidney or liver impairment and in elderly patients. Not recommended in type 1 diabetes or diabetic ketoacidosis. Seek medical help for severe abdominal pain, jaundice, or allergic reactions. Regular monitoring of blood glucose, HbA1c, and liver function may be advised.

Do not take Glynamic-Mv 3/0.3 mg if

Not for anyone with a known allergy to this medicine or to any ingredient in the pack. Not for type 1 diabetes or for diabetic ketoacidosis. Not for people with severe kidney or liver disease. Not for people with heart failure, active bladder cancer or unexplained blood in the urine.

Interactions with other medicines

Other antidiabetics/insulin (increased hypoglycaemia), alcohol (may increase hypoglycaemia), beta-blockers (may mask hypoglycaemia symptoms), corticosteroids and thiazide diuretics (may raise glucose), ACE inhibitors (may enhance glucose-lowering), fluoroquinolones (glucose disturbances), NSAIDs/salicylates (may increase sulfonylurea effect), azole antifungals and macrolides (may increase glimepiride levels)

How to store Glynamic-Mv 3/0.3 mg Tablet

Store below 25°C in a cool, dry place away from moisture and direct light. Keep in original blister pack and out of reach of children.

Expert advice for Glynamic-Mv 3/0.3 mg Tablet

Take it shortly before a meal, and eat that meal. Check your sugar as often as your doctor has asked, especially when your routine changes. Take it with the first mouthful of your meal so it can act on that meal. Expect some wind in the first weeks; it usually settles.

Manufacturer and class

Manufacturer:

FUSION HEALTH CARE

Therapeutic class:

Antidiabetic

Drug class:

Sulfonylurea + Alpha-glucosidase inhibitor